AI Cancer-Fighting Iambic Therapeutics Stock (IAM) Rockets 13% After $150M IPO
Shares in Nvidia ($NVDA)-backed cancer-fighting biotech Iambic Therapeutics ($IAM) soared 13% on its first day of trading following its U.S. IPO. T...
Bayer Ag (BAYRY)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Kahn Brothers Irving Kahn | 6,518,603 | $89,307,717 | +1% | 14.12% |
| 2. | Ancora Advisors Frederick Disanto | 710 | $9,727 | 0% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 128,634 | $1,736,565 | 0.01% | |
| 2. | 44,554 | $601,479 | 0.02% | |
| 3. | 19,414 | $264,340 | 0.04% | |
| 4. | 11,708 | $158,058 | 0% | |
| 5. | 3,264 | $44,064 | 0% |
News See All
12 Best German Dividend Stocks
In this article, we will take a detailed look at the12 Best German Dividend Stocks.
Should You Consider Acquiring Bayer (BAYRY) Shares?
Mittleman Brothers Investment Management, an investment management firm, published its first-quarter 2022 investor letter – a copy of which can be downloaded here.
Hedge Fund Resource Center